Filter
18 April 2024
In this paper, von Essen et al. examined the derivative effects of Ofatumumab in B cell depletion on the peripheral immune system and a direct treatment effect on T cells expressing CD20 in Multiple Sclerosis.
New insights in cell culture– dive into research with us | paper series part 10
8 April 2024
New faces at SABEU in first quarter of 2024!
We're thrilled to introduce the newest members of our SABEU family, who have joined us in the first quarter of 2024 >
4 April 2024
Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis
New insights in cell culture – dive into research with us | paper series part 9
19 March 2024
Investigated a new immunization strategy to identify novel receptors mediating transcytosis across the blood brain barrier
New insights in cell culture – dive into research with us | paper series part 8
13 March 2024
Insights into our latest cellQART product introductions live from SOT's ToxExpo 2024!
Watch our video and learn all about our groundbreaking new products and gain an exclusive insight into their development and functionality.
11 March 2024
Doors of Society of Toxicology (SOT)'s ToxExpo are opening soon!
Wishing our colleagues Jennifer Tanis-Hughes (Sales Lead Americas) and Dennis Benkmann (CEO) good luck at this year’s conference.
8 March 2024
NEW! 12-Well Empty and pre-loaded Well Plates >
Our newest addition is completing our cellQART Family! >
5 March 2024
In this paper, Phan et al. established two classes of lung-mimicking models: healthy and chronic obstructive pulmonary disease model
New insights in cell culture – dive into research with us | paper series part 7
25 February 2024
Second time at GöBit!
Last Saturday, our team had the fantastic opportunity to participate at GöBit (Göttingen's Career Information Day) for the second time.
22 February 2024
Accelerating the in vivo to in vitro work – Part 4/4 of cellQART's interview series with FRAME
Watch the last part of a series of interviews with Celean Camp, CEO of FRAME – Fund for the Replacement of Animals in Medical Experiments